The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, No.5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, 100088, China.
Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China.
BMC Psychiatry. 2020 Sep 29;20(1):474. doi: 10.1186/s12888-020-02885-6.
To assess the reliability and validity of Patient Health Questionnaire-9 (PHQ-9) for patients with major depressive disorder (MDD) and to assess the feasibility of its use in psychiatric hospitals in China.
One hundred nine outpatients or inpatients with MDD who qualified the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria completed PHQ-9 and Hamilton Depression Scale (HAMD-17). Two weeks after the initial evaluation, 54 randomly selected patients underwent repeat assessment using PHQ-9. For validity analysis, the construct validity and criterion validity were assessed. The internal concordance coefficient and the test-retest correlation coefficients were used for reliability analysis. The correlation between total score and scores for each item and the correlation between scores for various items were evaluated using Pearson correlation coefficient.
Principal components factor analysis showed good construct validity of the PHQ-9. PHQ-9 total score showed a positive correlation with HAMD-17 total score (r = 0.610, P < 0.001). With HAMD as the standard, PHQ-9 depression scores of 7, 15, and 21 points were used as cut-offs for mild, moderate, and severe depression, respectively. Consistency assessment was conducted between the depression severity as assessed by PHQ-9 and HAMD (Kappa = 0.229, P < 0.001). Intraclass correlation coefficient between PHQ-9 total score and HAMD total score was 0.594 (95% confidence interval, 0.456-0.704, P < 0.001). The Cronbach's α coefficient of PHQ-9 was 0.892. Correlation coefficients between each item score and the total score ranged from 0.567-0.789 (P < 0.01); the correlation coefficient between various item scores ranged from 0.233-0.747. The test-retest correlation coefficient for total score was 0.737.
PHQ-9 showed good reliability and validity, and high adaptability for patients with MDD in psychiatric hospital. It is a simple, rapid, effective, and reliable tool for screening and evaluation of the severity of depression.
评估 9 项患者健康问卷(PHQ-9)用于诊断重性抑郁障碍(MDD)患者的可靠性和有效性,并评估其在中国精神病院使用的可行性。
109 名符合精神障碍诊断与统计手册第四版(DSM-IV)标准的 MDD 门诊或住院患者完成 PHQ-9 和汉密尔顿抑郁量表(HAMD-17)。初次评估 2 周后,随机选择 54 名患者使用 PHQ-9 进行重复评估。为了进行有效性分析,评估了结构有效性和标准有效性。采用内部一致性系数和重测相关系数进行可靠性分析。采用 Pearson 相关系数评估总分和各项目得分之间的相关性以及各项目得分之间的相关性。
主成分因子分析显示 PHQ-9 具有良好的结构有效性。PHQ-9 总分与 HAMD-17 总分呈正相关(r=0.610,P<0.001)。以 HAMD 为标准,PHQ-9 抑郁评分 7、15 和 21 分分别作为轻度、中度和重度抑郁的切点。PHQ-9 评估的抑郁严重程度与 HAMD 之间的一致性评估(Kappa=0.229,P<0.001)。PHQ-9 总分与 HAMD 总分的组内相关系数为 0.594(95%置信区间,0.456-0.704,P<0.001)。PHQ-9 的 Cronbach's α 系数为 0.892。各项目得分与总分之间的相关系数范围为 0.567-0.789(P<0.01);各项目得分之间的相关系数范围为 0.233-0.747。总分的重测相关系数为 0.737。
PHQ-9 具有良好的可靠性和有效性,对精神病院 MDD 患者具有较高的适应性。它是一种简单、快速、有效、可靠的用于筛查和评估抑郁严重程度的工具。